Königs C - Search Results

1

Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A.

Holstein K, Albisetti M, Bidlingmaier C, Halimeh S, Heine S, Klamroth R, Königs C, Kurnik K, Male C, Oldenburg J, Streif W, Wermes C, Escuriola-Ettingshausen C; ‘Ständige Kommission Hämophilie’ (Haemophilia board) of the German, Swiss Austrian Society for Thrombosis Haemostasis Research (GTH). Holstein K, et al. Among authors: konigs c. Hamostaseologie. 2020 Dec;40(5):561-571. doi: 10.1055/a-1127-6476. Epub 2020 Jun 25. Hamostaseologie. 2020. PMID: 32588417 Review.

2

Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.

Olivieri M, Königs C, Heller C, Horneff S, Oldenburg J, Halimeh S, Kentouche K, Knöfler R, Fischer L, Pfrepper C, Kurnik K, Bidlingmaier C. Olivieri M, et al. Among authors: konigs c. Hamostaseologie. 2019 Nov;39(4):355-359. doi: 10.1055/s-0039-1677874. Epub 2019 Feb 5. Hamostaseologie. 2019. PMID: 30722069

3

[Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren].

Eichler H, Pedroni MA, Halimeh S, Königs C, Langer F, Miesbach W, Oldenburg J, Scholz U, Streif W, Klamroth R. Eichler H, et al. Among authors: konigs c. Hamostaseologie. 2019 Nov;39(4):311-321. doi: 10.1055/s-0039-1688450. Epub 2019 Apr 24. Hamostaseologie. 2019. PMID: 31018219 German. No abstract available.

4

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A.

Bachelet D, Albert T, Mbogning C, Hässler S, Zhang Y, Schultze-Strasser S, Repessé Y, Rayes J, Pavlova A, Pezeshkpoor B, Liphardt K, Davidson JE, Hincelin-Méry A, Dönnes P, Lacroix-Desmazes S, Königs C, Oldenburg J, Broët P; ABIRISK consortium. Bachelet D, et al. Among authors: konigs c. PLoS One. 2019 Jun 13;14(6):e0218258. doi: 10.1371/journal.pone.0218258. eCollection 2019. PLoS One. 2019. PMID: 31194850 Free PMC article.

5

Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 Study.

Türkantoz H, Königs C, Knöbl P, Klamroth R, Holstein K, Huth-Kühne A, Heinz J, Eichler H, Tiede A. Türkantoz H, et al. Among authors: konigs c. J Thromb Haemost. 2020 Jan;18(1):36-43. doi: 10.1111/jth.14618. Epub 2019 Sep 12. J Thromb Haemost. 2020. PMID: 31448877 Free article.

6

Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years.

Kittler SFK, Miesbach W, Bauhofer A, Becker T, Schüttrumpf J, Dubovy P, Nemes L, Richter H, Königs C. Kittler SFK, et al. Among authors: konigs c. Hamostaseologie. 2019 Nov;39(4):360-367. doi: 10.1055/s-0039-1698810. Epub 2019 Oct 24. Hamostaseologie. 2019. PMID: 31648354

7

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study.

Male C, Andersson NG, Rafowicz A, Liesner R, Kurnik K, Fischer K, Platokouki H, Santagostino E, Chambost H, Nolan B, Königs C, Kenet G, Ljung R, Van den Berg M. Male C, et al. Among authors: konigs c. Haematologica. 2021 Jan 1;106(1):123-129. doi: 10.3324/haematol.2019.239160. Haematologica. 2021. PMID: 31919092 Free PMC article.

8

Long-term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A.

Miesbach W, Kittler S, Bauhofer A, Königs C, Becker T, Nemes L, Staus A, Schüttrumpf J. Miesbach W, et al. Among authors: konigs c. Haemophilia. 2020 May;26(3):467-477. doi: 10.1111/hae.13988. Epub 2020 Apr 15. Haemophilia. 2020. PMID: 32293085

9

Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.

Escuriola-Ettingshausen C, Auerswald G, Königs C, Kurnik K, Scholz U, Klamroth R, Oldenburg J. Escuriola-Ettingshausen C, et al. Among authors: konigs c. Haemophilia. 2021 May;27(3):e305-e313. doi: 10.1111/hae.14010. Epub 2020 Sep 16. Haemophilia. 2021. PMID: 32937002 Review.

10

Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia.

Pfrepper C, Holstein K, Königs C, Heller C, Krause M, Olivieri M, Bidlingmaier C, Sigl-Kraetzig M, Wendisch J, Halimeh S, Horneff S, Richter H, Wieland I, Klamroth R, Oldenburg J, Tiede A; Hemophilia Board of the German, Austrian, Swiss Society on Thrombosis Hemostasis Research (GTH). Pfrepper C, et al. Among authors: konigs c. Hamostaseologie. 2021 Jun;41(3):190-196. doi: 10.1055/a-1401-2691. Epub 2021 Apr 15. Hamostaseologie. 2021. PMID: 33860513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters